These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 18541688)
21. Sterility testing of antimicrobial-containing injectable solutions prepared in the pharmacy. Akers MJ; Wright GE; Carlson KA Am J Hosp Pharm; 1991 Nov; 48(11):2414-8. PubMed ID: 1746574 [TBL] [Abstract][Full Text] [Related]
22. Method for testing the sterility of total nutrient admixtures. Levchuk JW; Nolly RJ; Lander N Am J Hosp Pharm; 1988 Jun; 45(6):1311-21. PubMed ID: 3137813 [TBL] [Abstract][Full Text] [Related]
23. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations. Allen LV; Okeke CC Int J Pharm Compd; 2008; 12(1):54-60. PubMed ID: 23969573 [TBL] [Abstract][Full Text] [Related]
25. [Hygienic precautions and microbiological quality control during the manufacturing of sterile drugs]. Züge R Zentralbl Bakteriol Mikrobiol Hyg B; 1982 May; 176(2-3):134-41. PubMed ID: 7124163 [TBL] [Abstract][Full Text] [Related]
26. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 12. Allen LV; Okeke CC Int J Pharm Compd; 2009; 13(2):146-50. PubMed ID: 23970008 [TBL] [Abstract][Full Text] [Related]
27. An analysis of 72% chromated glycerin used for sclerotherapy: sterility, potency, and cost after extended shelf life. Ghaznavi AM; Nakamura M; Tepper D Dermatol Surg; 2015 Jan; 41(1):121-5. PubMed ID: 25521102 [TBL] [Abstract][Full Text] [Related]
28. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use. Formea CM; Weiss WT; McCluskey SV Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018 [TBL] [Abstract][Full Text] [Related]
29. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 18: verification of automated compounding devices for parenteral nutrition compounding and finished preparation release checks and tests. Allen LV; Okeke CC Int J Pharm Compd; 2010; 14(2):142-9. PubMed ID: 23965426 [TBL] [Abstract][Full Text] [Related]
30. Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing. Belanger AP; Byrne JF; Paolino JM; DeGrado TR Nucl Med Biol; 2009 Nov; 36(8):955-9. PubMed ID: 19875052 [TBL] [Abstract][Full Text] [Related]
31. Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration. Paese K; Ortiz M; Frank LA; Külkamp-Guerreiro IC; Rolim CM; Barros DM; Pohlmann AR; Guterres SS AAPS PharmSciTech; 2017 Jan; 18(1):212-223. PubMed ID: 26956145 [TBL] [Abstract][Full Text] [Related]
32. Determination of the efficacy of sterile barrier systems against microbial challenges during transport and storage. Dunkelberg H; Schmelz U Infect Control Hosp Epidemiol; 2009 Feb; 30(2):179-83. PubMed ID: 19090770 [TBL] [Abstract][Full Text] [Related]
33. [Depyrogenation test regarding inox and glass containers in the preparation of parenteral nutrition mixtures]. Lajoinie A; Vasselon P; Tall ML; Salmon D; Bréant V; Diouf E; Pivot C; Pirot F Ann Pharm Fr; 2012 Sep; 70(5):271-80. PubMed ID: 23020918 [TBL] [Abstract][Full Text] [Related]
34. [On a note on the sterilization of glycerin]. TOELKE S Pharm Prax; 1961; 9():154-5. PubMed ID: 13921521 [No Abstract] [Full Text] [Related]
35. [On an observation on the sterilization of glycerin]. TOELKE S Pharm Prax; 1961; 9():154-5. PubMed ID: 13921522 [No Abstract] [Full Text] [Related]
36. [Aseptic process validation and stability study of an injectable preparation of fructose (5%)-glycerol (10%) as part of a hospital clinical research program on endoscopic curative treatment for early epithelial neoplastic lesions of the gastrointestinal tract]. Tall ML; Salmon D; Diouf E; Drai J; Filali S; Lépilliez V; Pioche M; Laleye D; Dhelens C; Ponchon T; Pivot C; Pirot F Ann Pharm Fr; 2015 Mar; 73(2):139-49. PubMed ID: 25745945 [TBL] [Abstract][Full Text] [Related]
37. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy. Hung JC; Anderson MM J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891 [TBL] [Abstract][Full Text] [Related]
38. Basics of compounding sterile preparations: nomenclature and considerations. Allen LV Int J Pharm Compd; 2014; 18(4):313-7. PubMed ID: 25474860 [TBL] [Abstract][Full Text] [Related]
39. [Stability and sterility of parenteral nutrition admixture for patients home care manufactured by the automated compounding BAXA® EM 2400]. Chappuy L; Charroin C; Vételé F; Durand T; Quessada T; Klotz MC; Pirot F; Bréant V; Aulagner G Ann Pharm Fr; 2013 Nov; 71(6):401-9. PubMed ID: 24206592 [TBL] [Abstract][Full Text] [Related]
40. Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry. Brown H; Mahler HC; Mellman J; Nieto A; Wagner D; Schaar M; Mathaes R; Kossinna J; Schmitting F; Dreher S; Roehl H; Hemminger M; Wuchner K PDA J Pharm Sci Technol; 2017; 71(2):147-162. PubMed ID: 27789803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]